List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Cholera - Overview
Cholera - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Cholera - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Cholera - Companies Involved in Therapeutics Development
Akthelia Pharmaceuticals Ltd
Beijing Minhai Biotechnology Co Ltd
po Pharmaceuticals Inc
Cholera - Drug Profiles
AKT-10082 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cholera (trivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cholera (whole cell) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cholera [serotypes O1 + O139] (bivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cholera [strain O1/El/Tor/Ogawa] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cholera vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cholera vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cholvax - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
crofelemer DR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
gram-negative bacterial infections vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IMSUTMR-1501 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LB-2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peptide for Cholera and Guillain-Barre Syndrome - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Bacterial Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Sialic Acid Permease for Gram Negative Bacterial Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptides to Disrupt Cell Membrane for Bacterial and Fungal Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cholera - Dormant Projects
Cholera - Discontinued Products
Cholera - Product Development Milestones
Featured News & Press Releases
Jun 13, 2018: Fast-acting Cholera Vaccine Could Curb Outbreaks
Apr 27, 2016: Hilleman Laboratories Provides Phase I/II Update on Cholera Vaccine
Feb 03, 2015: po Files Brief on Appeal In Dispute With Salix
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer